Tag:
resveratrol
Latest Headlines
Latest Headlines
Sirtris co-founder fires back against resveratrol critics
David Sinclair and his allies believe he has scored a major victory in the controversial--and complex--field of anti-aging science. With a new research paper, the Harvard genetics professor shows how the red wine chemical resveratrol and other compounds directly activate an enzyme called SIRT1, an activity on the target that has been hotly contested.
Resveratrol boosts metabolic function in human study
There's a fresh batch of data on the anti-aging chemical resveratrol for scientists to puzzle over. In an 11-person, double-blind study, researchers in the Netherlands and Switzerland found that some
Upstart Verastem challenges Wall Street with puzzling $50M IPO
Just a few months ago Christoph Westphal's new biotech, Verastem, raised a hefty $32 million Series B round based on the promise of the developer's cancer stem cell technology and a trio of noted
GSK-owned Sirtris drug extends lives of obese mice
After biotech Sirtris' anti-aging science took a shelling in recent years, one of the firm's drugs that mimics the red wine chemical resveratrol showed in a new study that it could extend the average
Danes begin biggest-ever resveratrol study
Resveratrol, a compound found in red wine that's thought to increase longevity, has long been a darling of those who promote so-called "natural" health products--not to mention those who follow
Weak efficacy, renal risks force GSK to dump a resveratrol program
GlaxoSmithKline is dumping its program for SRT501 , a special formulation of resveratrol which the pharma company scooped up in the $720 million buyout of Sirtris in 2008. GSK suspended a Phase IIa
GSK orders Sirtris execs to stop selling resveratrol
GlaxoSmithKline (NYSE: GSK) has ordered two Sirtris executives--Christoph Westphal and Michelle Dipp--to stop selling a resveratrol dietary supplement based on the drug the two companies have in
Glaxo spurns new research raising doubts about resveratrol
Over the past few years resveratrol has emerged as one of the most closely-tracked development programs in biotechnology. GlaxoSmithKline paid $720 million to buy Sirtris Pharmaceuticals back in 2007
Science team highlights new approach to obesity
The therapeutic promise of activating Sirt1 to spur weight loss and increase longevity has already generated significant R&D interest. Now researchers at Brown University, Rhode Island Hospital
Scientists successfully treat diabetes with resveratrol
A new study highlights the prospective benefits of using resveratrol, an element in red wine, for the treatment of diabetes. Resveratrol has been in the scientific spotlight for several years now as
